AVE 16.7% 0.3¢ avecho biotechnology limited

Ann: Updated Presentation to Support CEO Partnering Meetings, page-49

  1. 2,811 Posts.
    lightbulb Created with Sketch. 519
    The veterinary product under development with a third party may be propofol or it could be something else.Even if it is not profotol at this time the vetinary use of propofol is extensive and surely must be of interest to AVE if not Terumo.​

    Aparently in some countries propofol is only approved for vetinary use:The following list of vetinary products approved for use in various countries ​
    is just a random selection as follows:​

    Proposure[UK]​

    Aquafol[Australia]​

    Naarcofol[Germany]​

    Norofol[UK]​

    Propo Clear[US]​

    Propo[Netherlands]​

    Propoflo[US]​

    Propoflo Plus[UK]​

    Vetofol[France] ​

    Just to pick one product from the above list[just because it was easy] vetofol is manufactured by Norbrook Laboratories in Ireland [a vetinary product only pharma manufacturer].This type of pharma could be interested in the companys current propofol research. ​

    Kens ​
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $25 10.00K

Buyers (Bids)

No. Vol. Price($)
66 91668236 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 62801585 14
View Market Depth
Last trade - 15.34pm 23/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.